PEGylated Elesclomol@Cu(Ⅱ)-based Metal‒organic framework with effective nanozyme performance and cuproptosis induction efficacy for enhanced PD-L1-based immunotherapy.
- DOI
- 10.1016/j.mtbio.2024.101317
- Published
- 2024 Dec
- Container
- Materials today. Bio
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.mtbio.2024.101317,
title = {PEGylated Elesclomol@Cu(Ⅱ)-based Metal‒organic framework with effective nanozyme performance and cuproptosis induction efficacy for enhanced PD-L1-based immunotherapy.},
author = {Lu X and Deng W and Wang S and Zhao S and Zhu B and Bai B and Mao Y and Lin J and Yi Y and Xie Z and Wang X and Lu Y and Huang X and You T and Chen X and Sun W and Shen X},
year = {2024},
journal = {Materials today. Bio},
doi = {10.1016/j.mtbio.2024.101317},
url = {https://doi.org/10.1016/j.mtbio.2024.101317}
}RIS
TY - JOUR TI - PEGylated Elesclomol@Cu(Ⅱ)-based Metal‒organic framework with effective nanozyme performance and cuproptosis induction efficacy for enhanced PD-L1-based immunotherapy. AU - Lu X AU - Deng W AU - Wang S AU - Zhao S AU - Zhu B AU - Bai B AU - Mao Y AU - Lin J AU - Yi Y AU - Xie Z AU - Wang X AU - Lu Y AU - Huang X AU - You T AU - Chen X AU - Sun W AU - Shen X PY - 2024 JO - Materials today. Bio DO - 10.1016/j.mtbio.2024.101317 UR - https://doi.org/10.1016/j.mtbio.2024.101317 ER -
APA
X, L., W, D., S, W., S, Z., B, Z., B, B., Y, M., J, L., Y, Y., Z, X., X, W., Y, L., X, H., T, Y., X, C., W, S., & X, S. (2024). PEGylated Elesclomol@Cu(Ⅱ)-based Metal‒organic framework with effective nanozyme performance and cuproptosis induction efficacy for enhanced PD-L1-based immunotherapy.. Materials today. Bio. https://doi.org/10.1016/j.mtbio.2024.101317
Source records
- pubmed · retrieved 2026-09-25T11:13:26.718Z